Author:
Velásquez Ilais Moreno,Frumento Paolo,Johansson Katarina,Berglund Anita,de Faire Ulf,Leander Karin,Gigante Bruna
Funder
Swedish Heart and Lung Foundation
Strategic Research Program in Epidemiology
Erasmus Columbus project (ERACOL)
Subject
Cardiology and Cardiovascular Medicine
Reference44 articles.
1. Interleukin 8 and cardiovascular disease;Apostolakis;Cardiovasc Res,2009
2. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor;Ahuja;J Biol Chem,1996
3. Interleukin-8 and its receptor CXCR2 in atherosclerosis;Boisvert;Immunol Res,2000
4. Modulation of atherogenesis by chemokines;Boisvert;Trends Cardiovasc Med,2004
5. The IL-6-soluble IL-6Ralpha autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin;Marin;J Immunol,2001